Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Medication errors related to product names.

John P Santell¹, Diane D Cousins

¹Educational Program Initiatives, United States Pharmacopeia (USP) Center for the Advancement of Patient Safety, Rockville, Maryland, USA. jps@usp.org

Joint Commission Journal on Quality and Patient Safety

|December 13, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Medication errors resulting from computer entry by nonprescribers.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2009

Same author

The National Coordinating Council for Medication Error Reporting and Prevention: promoting patient safety and quality through innovation and leadership.

Joint Commission journal on quality and patient safety·2009

Same author

How useful are voluntary medication error reports? The case of warfarin-related medication errors.

Joint Commission journal on quality and patient safety·2008

Same author

Medication errors involving patient-controlled analgesia.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2008

Same author

The impact of abbreviations on patient safety.

Joint Commission journal on quality and patient safety·2007

Same author

Technological methods used to prevent errors aren't infallible.

Materials management in health care·2007

Same journal

Implementing the SSKIN Bundle in Home Healthcare: A Tool Tutorial for Reducing Pressure Injuries.

Joint Commission journal on quality and patient safety·2026

Same journal

How Collaboration Between Surgeons and Medical Oncologists Affects Outcomes for Patients with Pancreatic Cancer.

Joint Commission journal on quality and patient safety·2026

Same journal

Uneven Compassion and the Emotional Safety of the Healthcare Workforce.

Joint Commission journal on quality and patient safety·2026

Same journal

Development and Implementation of a Machine Learning Model for Prediction of Surgical Case Duration.

Joint Commission journal on quality and patient safety·2026

Same journal

Decreasing Herpes Simplex Virus (HSV) Testing Turnaround Time for Infants in a Hospital Setting: A Continuous Quality Improvement Project.

Joint Commission journal on quality and patient safety·2026

Same journal

Symptom Tracking in Primary Care: Designing and Testing an EHR-Embedded Safety-Net System.

Joint Commission journal on quality and patient safety·2026

See all related articles

Confusing drug product names can lead to medication errors. Collaboration among the Food and Drug Administration (FDA), manufacturers, pharmacists, and patients is crucial to minimize these risks.

Area of Science:

Pharmaceutical Sciences
Medication Safety
Health Policy

Background:

Product naming conventions in pharmaceuticals can create confusion.
This confusion is a significant contributing factor to medication errors, including incorrect drug selection and dosage inaccuracies.

Purpose of the Study:

To highlight the risks associated with ambiguous drug product naming.
To emphasize the collective responsibility in mitigating medication errors stemming from naming confusion.

Main Methods:

Review of existing literature and FDA guidelines on drug nomenclature.
Analysis of reported medication error data linked to product naming.

Main Results:

Product naming ambiguity is a direct cause of medication errors.

Related Experiment Videos

Interventions involving multiple stakeholders are necessary for error reduction.

Conclusions:

Standardized and clear drug naming practices are essential for patient safety.
A multi-stakeholder approach involving regulatory bodies, industry, healthcare professionals, and patients is vital to reduce medication errors related to drug confusion.